PMID: 29847963Jun 1, 2018Paper

Occlusal Palliation of a Hematopoietic Stem Cell Transplant Patient

Compendium of Continuing Education in Dentistry
Hilary Pada

Abstract

Dental providers are integral to patients preparing for hematopoietic stem cell transplantation (HSCT) and for survivorship care. Following successful treatment, HSCT patients eventually return to the care of a general dentist, who must understand the importance of assessing and managing these individuals in collaboration with medical colleagues. This case report describes the dental therapy of a patient diagnosed with multiple myeloma who was experiencing teeth chipping in the anterior, clenching, and myofascial tension. The three-phase treatment plan was aimed at creating a relaxed, comfortable bite position, preventing further functional damage, and optimizing the patient's dental/medical health for her survival prognosis of 2 to 4 years.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Lu-ping YuXiao-feng Wang
Quintessence International, Dental Digest
W B Dragan
Current Opinion in Hematology
Małgorzata MikulskaClaudio Viscoli
© 2022 Meta ULC. All rights reserved